Symposia: Allogeneic Transplantation: Long-term Follow-up, Complications, and Disease Recurrence
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Lymphoid Leukemias, Clinical trials, Adult, AML, Acute Myeloid Malignancies, Bone Marrow Failure Syndromes, Lymphomas, Clinical Research, Health outcomes research, Aplastic Anemia, Genomics, Diseases, Real-world evidence, Biological therapies, Treatment Considerations, Aggressive lymphoma, Registries, Lymphoid Malignancies, Young adult , Survivorship, Myeloid Malignancies, Biological Processes, Study Population, Human, Transplantation (Allogeneic and Autologous)
Type: Oral
Hematology Disease Topics & Pathways:
Research, Lymphoid Leukemias, Clinical trials, Adult, AML, Acute Myeloid Malignancies, Bone Marrow Failure Syndromes, Lymphomas, Clinical Research, Health outcomes research, Aplastic Anemia, Genomics, Diseases, Real-world evidence, Biological therapies, Treatment Considerations, Aggressive lymphoma, Registries, Lymphoid Malignancies, Young adult , Survivorship, Myeloid Malignancies, Biological Processes, Study Population, Human, Transplantation (Allogeneic and Autologous)
Sunday, December 8, 2024: 12:00 PM-1:30 PM
Room 11
(San Diego Convention Center)
Moderators:
Michael Scordo, MD, Memorial Sloan Kettering Cancer Center
and
Mariam T. Nawas, MD, Department of Medicine, Section of Hematology/Oncology, University of Chicago
Disclosures:
No relevant conflicts of interest to declare.
This session consists of abstracts describing long term outcomes of and risk factors for survival after allogeneic hematopoietic cell transplant. Most of this session focuses on outcomes of rarer diseases such as NK/T cell leukemia, T-prolymphocytic leukemia and aplastic anemia.
12:00 PM
12:15 PM
12:30 PM
12:45 PM
1:00 PM
1:15 PM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH